Breast cancer starts in breast tissue, often in ducts or lobules, and can spread to surrounding tissue or other parts of the body. It is one of the most common cancers in women, but it is also treatable when detected early. Advances in personalized medicine, genetic testing, and targeted therapies have dramatically improved survival rates.
Certain lifestyle factors increase the likelihood of developing breast cancer by influencing hormone levels, inflammation, and cellular processes.
Postmenopausal women with excess body fat have higher estrogen levels, promoting tumor growth.
Linked to excess body fat and hormonal imbalance.
Prolonged use of combined estrogen-progesterone therapy increases the risk.
Increases estrogen levels and DNA damage.
Early detection improves outcomes. Recognizing the symptoms is crucial for rapid intervention.
Discomfort caused by reduced blood flow to the heart.
Indicates a decrease in oxygen supply due to restricted blood flow.
Pecks, redness, or thickenings that look like orange skin.
Rare, but may occur in some cases.
Asymmetry or visible differences between breasts.
Comprehensive diagnostic approaches combine imaging, biomarkers, and genetic testing for accurate detection.
Measures the number of atherogenic lipoproteins.
Confirm the diagnosis by analyzing tissue samples.
Confirm the diagnosis by analyzing tissue samples.
Determines the overexpression of the HER2 protein, essential for targeted therapy.
BRCA1/BRCA2 mutations: Significantly increase the lifetime risk of breast cancer.
High risk
Carriers of positive mutations have up to 70% lifetime risk.
Normal
Negative for BRCA mutations.
Treatment varies according to the stage of the cancer, the status of the receptors, and the health of the patient, with an emphasis on personalized approaches.
Systemic treatment for aggressive or metastatic cancers.
Often combined with surgery to remove residual cancer cells.